Smithbridge Asset Management Inc Novartis Ag Transaction History

Smithbridge Asset Management Inc

  • $573 Million
  • Q3 2024

A detailed history of Smithbridge Asset Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 47,049 shares of NVS stock, worth $4.91 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
47,049
Previous 46,230 1.77%
Holding current value
$4.91 Million
Previous $4.92 Million 9.96%
% of portfolio
0.94%
Previous 1.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$106.13 - $120.89 $86,920 - $99,008
819 Added 1.77%
47,049 $5.41 Million
Q2 2024

Jul 19, 2024
BUY
$92.57 - $107.37 $32,492 - $37,686
351 Added 0.77%
46,230 $4.92 Million
Q1 2024

May 03, 2024
SELL
$95.27 - $108.47 $37,822 - $43,062
-397 Reduced 0.86%
45,879 $4.44 Million
Q4 2023

Jan 18, 2024
BUY
$92.27 - $101.54 $35,708 - $39,295
387 Added 0.84%
46,276 $4.67 Million
Q3 2023

Oct 25, 2023
BUY
$94.73 - $105.13 $189,649 - $210,470
2,002 Added 4.56%
45,889 $4.67 Million
Q2 2023

Jul 20, 2023
BUY
$92.52 - $104.91 $301,615 - $342,006
3,260 Added 8.02%
43,887 $4.43 Million
Q2 2023

Jul 18, 2023
SELL
$92.52 - $104.91 $126,752 - $143,726
-1,370 Reduced 3.26%
40,627 $3.69 Million
Q1 2023

Apr 20, 2023
BUY
$80.03 - $92.81 $109,641 - $127,149
1,370 Added 3.37%
41,997 $3.86 Million
Q4 2022

Mar 01, 2023
SELL
$75.55 - $92.52 $417,338 - $511,080
-5,524 Reduced 11.97%
40,627 $3.69 Million
Q3 2022

Oct 25, 2022
BUY
$74.61 - $87.26 $166,977 - $195,287
2,238 Added 5.1%
46,151 $3.51 Million
Q2 2022

Aug 03, 2022
BUY
$80.52 - $93.75 $40,260 - $46,875
500 Added 1.15%
43,913 $3.71 Million
Q1 2022

Apr 25, 2022
BUY
$80.11 - $90.62 $116,079 - $131,308
1,449 Added 3.45%
43,413 $3.81 Million
Q4 2021

Jan 24, 2022
BUY
$79.7 - $88.13 $3.34 Million - $3.7 Million
41,964 New
41,964 $3.67 Million
Q3 2021

Oct 04, 2021
BUY
$81.78 - $95.14 $14,147 - $16,459
173 Added 0.42%
41,268 $3.38 Million
Q2 2021

Jul 23, 2021
BUY
$85.24 - $94.15 $95,895 - $105,918
1,125 Added 2.81%
41,095 $3.75 Million
Q1 2021

Apr 06, 2021
BUY
$83.5 - $98.47 $339,845 - $400,772
4,070 Added 11.34%
39,970 $3.42 Million
Q4 2020

Jan 21, 2021
SELL
$78.07 - $94.43 $45,670 - $55,241
-585 Reduced 1.6%
35,900 $3.39 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $27,516 - $30,485
335 Added 0.93%
36,485 $3.17 Million
Q2 2020

Jul 01, 2020
BUY
$80.93 - $91.1 $104,399 - $117,518
1,290 Added 3.7%
36,150 $3.16 Million
Q1 2020

Apr 13, 2020
BUY
$70.67 - $99.01 $120,775 - $169,208
1,709 Added 5.16%
34,860 $2.87 Million
Q4 2019

Jan 09, 2020
SELL
$84.35 - $95.37 $2.23 Million - $2.52 Million
-26,461 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$85.54 - $94.26 $179,634 - $197,946
2,100 Added 8.62%
26,461 $2.3 Million
Q2 2019

Jul 09, 2019
BUY
$75.4 - $92.8 $35,438 - $43,616
470 Added 1.97%
24,361 $2.22 Million
Q1 2019

Apr 03, 2019
BUY
$75.32 - $86.15 $124,277 - $142,147
1,650 Added 7.42%
23,891 $2.3 Million
Q4 2018

Jan 15, 2019
BUY
$73.66 - $82.02 $96,641 - $107,610
1,312 Added 6.27%
22,241 $1.91 Million
Q3 2018

Oct 05, 2018
SELL
$66.94 - $77.43 $8,367 - $9,678
-125 Reduced 0.59%
20,929 $1.8 Million
Q2 2018

Jul 18, 2018
BUY
$64.91 - $73.36 $56,796 - $64,190
875 Added 4.34%
21,054 $1.59 Million
Q1 2018

Apr 09, 2018
BUY
$70.39 - $84.15 $184,492 - $220,557
2,621 Added 14.93%
20,179 $1.63 Million
Q4 2017

Jan 18, 2018
BUY
$72.33 - $77.64 $544,644 - $584,629
7,530 Added 75.09%
17,558 $1.47 Million
Q3 2017

Oct 12, 2017
BUY
$74.14 - $77.27 $743,475 - $774,863
10,028
10,028 $861,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Smithbridge Asset Management Inc Portfolio

Follow Smithbridge Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email